Erdosteine

Indications

Acute and chronic respiratory disorders associated with excessive mucus production.

Chronic bronchitis and acute exacerbations of chronic bronchitis.

Respiratory conditions associated with thick or viscous bronchial secretions.

Facilitates the clearance and expectoration of mucus.

+91 85919 78885

Capsule

Erdosteine 300 mg Capsules contain erdosteine, a mucolytic agent used to help reduce the viscosity of thick respiratory mucus and facilitate its clearance from the airways. Erdosteine is a prodrug that is metabolised to an active metabolite containing a free thiol group. This active metabolite acts on disulphide bonds within bronchial mucoproteins, contributing to the reduction of mucus viscosity and supporting expectoration. Erdosteine also possesses antioxidant properties and has been shown to influence bacterial adhesion to respiratory epithelial cells in pharmacological studies. The 300 mg capsule is an oral pharmaceutical dosage form intended for use according to the prescribing information and under appropriate medical supervision.

Speciality	Respiratory Medicine / Pulmonology
Tags	Erdosteine Capsules, Mucolytic, Expectorant, Respiratory Medicine, Mucus Clearance, Chronic Bronchitis, Respiratory Secretions, Pulmonary Care
Strength	Erdosteine 300 mg
Packing Size	10 x 10

Check all Capsules Range

Click to know More

Mechanism

Erdosteine is administered as a prodrug and undergoes first-pass metabolism to form its pharmacologically active metabolite, which contains a free thiol group. The active metabolite acts on disulphide bonds present in bronchial mucoproteins, thereby reducing the viscosity and adhesiveness of thick mucus and facilitating its clearance through expectoration. Erdosteine has also demonstrated antioxidant activity related to its active thiol-containing metabolite and has been shown in pharmacological studies to inhibit bacterial adhesion to respiratory epithelial cells. These actions contribute to its mucolytic and expectorant effects.

Dosage

As directed by the Physician.

Side Effects

Taste disturbance
Vomiting
Headache

Contraindication

Erdosteine is contraindicated in patients with hypersensitivity to erdosteine or any of the formulation excipients. It is also contraindicated/not recommended in patients with severe renal impairment or severe hepatic impairment and in patients with active peptic ulcer disease, according to the referenced product information. The medicine should not be used in patients with a known allergy to the active ingredient or relevant excipients.

Warning and Precautions

Do not exceed the recommended dose or daily usage.
Keep out of reach of children.
Patients with mild hepatic impairment should not exceed 300 mg per day.
During pregnancy or breastfeeding only when specifically considered appropriate by the treating healthcare professional .
Store in a cool, dry place away from direct sunlight and moisture.
Patients should inform their doctor about existing medical conditions and all medicines being taken before starting treatment.

All product details on this website are for reference and informational purposes only and are not directed at patients or consumers.
As a contract manufacturer, DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all liability arising from reliance on this information.
Please consult a healthcare professional before using any medicinal product.